The Whole Truth
Science & Research
Latest Research
Go Back
Jul 13, 2006
Zyflamend-mediated Inhibition of Human PC3 Cell Proliferation: Effects on 12-LOX and Rb Protein Phosphotylation
[ Download PDF ]
Peiying Yang, Diana Chan, Mary Vijjeswarapu, Carrie Cartwright, Ding Jibin, and Robert A Newman

The multiherb anti-inflammatory product Zyflamend was investigated for its anti-proliferative effects on human prostate cancer PC3 cells and specifically evaluated for its effects on eicosanoid metabolism in this prostate cancer cell line

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.